Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoe
WST
FLIC, PGY, HLF, BSBK, LCNB, IMRX, CRMT, MRBK, FRST, NYCB, GRNT, OVLY, GEF-B, NBBK, HBT, BOTJ, EG, AMN, HNVR, TISI, MDRR, RLMD, BTSG, BBGI, COLB
FLIC, PGY, HLF, BSBK, LCNB, IMRX, CRMT, MRBK, FRST, NYCB, GRNT, OVLY, GEF-B, NBBK, HBT, BOTJ, EG, AMN, HNVR, TISI, MDRR, RLMD, BTSG, BBGI, COLB
FLIC, HLF, PGY, BSBK, LCNB, IMRX, CRMT, MRBK, FRST, NYCB, GRNT, OVLY, GEF-B, NBBK, HBT, BOTJ, AMN, EG, HNVR, TISI, MDRR, RLMD, BTSG, BBGI, COLB
WST